These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33594385)

  • 1. Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677.
    Hodcroft EB; Domman DB; Snyder DJ; Oguntuyo KY; Van Diest M; Densmore KH; Schwalm KC; Femling J; Carroll JL; Scott RS; Whyte MM; Edwards MW; Hull NC; Kevil CG; Vanchiere JA; Lee B; Dinwiddie DL; Cooper VS; Kamil JP
    medRxiv; 2021 Feb; ():. PubMed ID: 33594385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants.
    Tchesnokova V; Kulakesara H; Larson L; Bowers V; Rechkina E; Kisiela D; Sledneva Y; Choudhury D; Maslova I; Deng K; Kutumbaka K; Geng H; Fowler C; Greene D; Ralston J; Samadpour M; Sokurenko E
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.
    Tchesnokova V; Kulasekara H; Larson L; Bowers V; Rechkina E; Kisiela D; Sledneva Y; Choudhury D; Maslova I; Deng K; Kutumbaka K; Geng H; Fowler C; Greene D; Ralston J; Samadpour M; Sokurenko E
    J Clin Microbiol; 2021 Oct; 59(11):e0092121. PubMed ID: 34379531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity.
    Ridgway H; Ntallis C; Chasapis CT; Kelaidonis K; Matsoukas MT; Plotas P; Apostolopoulos V; Moore G; Tsiodras S; Paraskevis D; Mavromoustakos T; Matsoukas JM
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851526
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.
    Oliveira MM; Schemberger MO; Suzukawa AA; Riediger IN; do Carmo Debur M; Becker G; Resende PC; Gräf T; Balsanelli E; de Baura VA; de Souza EM; Pedrosa FO; Alves LR; Blanes L; Nardelli SC; Aguiar AM; Albrecht L; Zanette D; Ávila AR; Morello LG; Marchini FK; Dos Santos HG; Passetti F; Dallagiovanna B; Faoro H
    Virol J; 2021 Nov; 18(1):222. PubMed ID: 34789293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
    Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG
    EBioMedicine; 2022 Oct; 84():104270. PubMed ID: 36130476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness.
    Yurkovetskiy L; Egri S; Kurhade C; Diaz-Salinas MA; Jaimes JA; Nyalile T; Xie X; Choudhary MC; Dauphin A; Li JZ; Munro JB; Shi PY; Shen K; Luban J
    bioRxiv; 2023 Apr; ():. PubMed ID: 37034621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of a substitution or deletion of SARS-CoV-2 spike amino acid 677 in various lineages in Marseille, France.
    Colson P; Delerce J; Burel E; Beye M; Fournier PE; Levasseur A; Lagier JC; Raoult D
    Virus Genes; 2022 Feb; 58(1):53-58. PubMed ID: 34839413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
    J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    bioRxiv; 2021 Aug; ():. PubMed ID: 34462749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
    Nagy A; Basiouni S; Parvin R; Hafez HM; Shehata AA
    Arch Virol; 2021 Sep; 166(9):2541-2549. PubMed ID: 34258664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.
    Grabowski F; Preibisch G; Giziński S; Kochańczyk M; Lipniacki T
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.